Joseph T Flynn1. 1. Division of Nephrology, Seattle Children's Hospital, Seattle, Washington 98105, USA. joseph.flynn@seattlechildrens.org
Abstract
PURPOSE OF REVIEW: The field of childhood hypertension has been changing rapidly since publication of the most recent consensus guidelines contained in the 2004 'Fourth Report'. RECENT FINDINGS: Several epidemiologic studies have indicated that the prevalence of hypertension in children and adolescents is on the increase. A major factor behind this increase is the childhood obesity epidemic. There is substantial new information on the frequency of hypertensive target-organ damage in the young, including vascular, cardiac and renal effects. These data have led some authorities to recommend changes in how hypertension is evaluated and managed in the young. SUMMARY: There has been significant new knowledge gained about many aspects of childhood hypertension over the past 5 years. Clinicians who care for children and adolescents with high blood pressure should familiarize themselves with these new data and incorporate them into their clinical decision-making.
PURPOSE OF REVIEW: The field of childhood hypertension has been changing rapidly since publication of the most recent consensus guidelines contained in the 2004 'Fourth Report'. RECENT FINDINGS: Several epidemiologic studies have indicated that the prevalence of hypertension in children and adolescents is on the increase. A major factor behind this increase is the childhood obesity epidemic. There is substantial new information on the frequency of hypertensive target-organ damage in the young, including vascular, cardiac and renal effects. These data have led some authorities to recommend changes in how hypertension is evaluated and managed in the young. SUMMARY: There has been significant new knowledge gained about many aspects of childhood hypertension over the past 5 years. Clinicians who care for children and adolescents with high blood pressure should familiarize themselves with these new data and incorporate them into their clinical decision-making.
Authors: Andrew C Tiu; Michael D Bishop; Laureano D Asico; Pedro A Jose; Van Anthony M Villar Journal: Curr Hypertens Rep Date: 2017-09 Impact factor: 5.369
Authors: Romina S Gomes; Isabel G Quirino; Regina M Pereira; Breno M Vitor; Alysson F Leite; Eduardo A Oliveira; Ana Cristina Simões e Silva Journal: Pediatr Nephrol Date: 2010-12-21 Impact factor: 3.714
Authors: Lauren F Loeffler; Ana Navas-Acien; Tammy M Brady; Edgar R Miller; Jeffrey J Fadrowski Journal: Hypertension Date: 2012-02-21 Impact factor: 10.190